BioSpace News Archive

Career Advice

Say “No” the Right Way: How Declining a Job Offer can Advance Your Career

Figuring out the best way to turn down a job offer is a “good” problem to have. If anything, receiving one or multiple job offers gives you a sense of your professional currency on the job market and could even make you a more attractive candidate for other potential employers.

March 2, 2018
·
4 min read
Drug Development

Ionis and Roche Tout Positive Data in Early-Stage Huntington’s Disease Trial

Late Thursday the companies touted biomarker data from an early-stage study that showed the drug lowered the disease-causing protein in people with the disease.

March 2, 2018
·
2 min read
·
Alex Keown
BioMidwest

Biogen and AbbVie Voluntarily Pull Multiple Sclerosis Drug Off the Market

Biogen and AbbVie have voluntarily pulled their Zinbryta for relapsing multiple sclerosis (MS) off the market after safety concerns.

March 2, 2018
·
2 min read
·
Mark Terry
Drug Development

MeiraGTx Earns EMA PRIME Designation for Achromatopsia Gene Therapy Candidate

A new gene therapy to treat a debilitating eye disorder is one step closer to regulatory approval in Europe.

March 2, 2018
·
2 min read
·
Alex Keown
FDA

FDA Issues New Draft Guidance for Alzheimer’s Trials that Could Open Up Approvals

The U.S. Food and Drug Administration (FDA) issued new draft guidance for preclinical trials in Alzheimer’s.

March 2, 2018
·
3 min read
·
Mark Terry
Business

OPKO Health’s Annual Report a Mixed Bag

OPKO Health’s fourth-quarter report highlighted positive activities in the face of a net loss of $213.9 million during the most recent quarter.

March 2, 2018
·
3 min read
·
Mark Terry
Drug Development

Sanofi and Regeneron Seek FDA Approval of Dupixent as Add-On Asthma Therapy

Asthma patients may soon have a new treatment option.

March 2, 2018
·
2 min read
·
Alex Keown
CARsgen Completed $60 Million Pre-C Financing Framework Agreements

CARsgen Therapeutics announces it has entered into a Pre-C financing framework agreement with receiving $60M equity investment from existing and new investors.

March 2, 2018
·
1 min read
Business

West Chief Financial Officer William Federici Announces Plans to Retire

West Pharmaceutical Services, Inc. announced William Federici, Senior Vice President, Chief Financial Officer and Treasurer, has communicated his intention to retire later this year.

March 2, 2018
·
1 min read
Pharm Country

Mylan to Introduce Two New Cost-Saving HIV Combination Treatments in the U.S.

Mylan will launch Symfi Lo and Cimduo at a significant discount to the price of competing products to bring cost savings to the $20 billion U.S. ARV market

March 2, 2018
·
7 min read